UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease

The journal of clinical endocrinology and metabolism, 2015-10, Vol.100 (10), p.3770-3777

2015

Volltextzugriff (PDF)

Transsphenoidal Surgery for Cushing Disease After Nondiagnostic Inferior Petrosal Sinus Sampling

Neurosurgery, 2012-07, Vol.71 (1), p.14-22

2012

Volltextzugriff (PDF)

Accuracy of Laboratory Tests for the Diagnosis of Cushing Syndrome

The journal of clinical endocrinology and metabolism, 2020-06, Vol.105 (6), p.2081-2094

2020

Volltextzugriff (PDF)

Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline

The journal of clinical endocrinology and metabolism, 2015-08, Vol.100 (8), p.2807-2831

2015

Volltextzugriff (PDF)

A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update

The journal of clinical endocrinology and metabolism, 2020-04, Vol.105 (4), p.e937-e946

2020

Volltextzugriff (PDF)

The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline

The journal of clinical endocrinology and metabolism, 2008-05, Vol.93 (5), p.1526-1540

2008

Volltextzugriff (PDF)

LCI699, a Potent 11β-hydroxylase Inhibitor, Normalizes Urinary Cortisol in Patients With Cushing's Disease: Results From a Multicenter, Proof-of-Concept Study

The journal of clinical endocrinology and metabolism, 2014-04, Vol.99 (4), p.1375-1383

2014

Volltextzugriff (PDF)

Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome

The journal of clinical endocrinology and metabolism, 2012-06, Vol.97 (6), p.2039-2049

2012

Volltextzugriff (PDF)

Exploring Inpatient Hospitalizations and Morbidity in Patients With Adrenal Insufficiency

The journal of clinical endocrinology and metabolism, 2016-12, Vol.101 (12), p.4843-4850

2016

Volltextzugriff (PDF)

Potential Cardiac Valve Effects of Dopamine Agonists in Hyperprolactinemia

The journal of clinical endocrinology and metabolism, 2010-03, Vol.95 (3), p.1025-1033

2010

Volltextzugriff (PDF)

Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial

The journal of clinical endocrinology and metabolism, 2020-04, Vol.105 (4), p.e1358-e1376

2020

Volltextzugriff (PDF)

Long-Term Safety of Pegvisomant in Patients with Acromegaly: Comprehensive Review of 1288 Subjects in ACROSTUDY

Pharmacotherapy, 2012-05, Vol.97 (5), p.1589-1597

2012

Volltextzugriff (PDF)

Dopamine Agonists Can Reduce Cystic Prolactinomas

The journal of clinical endocrinology and metabolism, 2016-10, Vol.101 (10), p.3709-3715

2016

Volltextzugriff (PDF)

Macimorelin as a Diagnostic Test for Adult GH Deficiency

The journal of clinical endocrinology and metabolism, 2018-08, Vol.103 (8), p.3083-3093

2018

Volltextzugriff (PDF)

Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY

European journal of endocrinology, 2018-12, Vol.179 (6), p.419

2018

Volltextzugriff (PDF)

Levoketoconazole treatment in endogenous Cushing's syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes

European journal of endocrinology, 2022-12, Vol.187 (6), p.859

2022

Volltextzugriff (PDF)

Increasing frequency of combination medical therapy in the treatment of acromegaly with the GH receptor antagonist pegvisomant

European journal of endocrinology, 2018-04, Vol.178 (4), p.321

2018

Volltextzugriff (PDF)

Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome

The journal of clinical endocrinology and metabolism, 2013-06, Vol.98 (6), p.E1072-E1087

2013

Volltextzugriff (PDF)

Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency

European journal of endocrinology, 2022-07, Vol.187 (1), p.27

2022

Volltextzugriff (PDF)

Use of late-night salivary cortisol to monitor response to medical treatment in Cushing's disease

European journal of endocrinology, 2020-02, Vol.182 (2), p.207

2020

Volltextzugriff (PDF)

Radiotherapy, Especially at Young Age, Increases the Risk for De Novo Brain Tumors in Patients Treated for Pituitary/Sellar Lesions

The journal of clinical endocrinology and metabolism, 2017-03, Vol.102 (3), p.1051-1058

2017

Volltextzugriff (PDF)

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations

European journal of endocrinology, 2016-06, Vol.174 (6), p.C1

2016

Volltextzugriff (PDF)

Delayed Remission after Transsphenoidal Surgery in Patients with Cushing’s Disease

The journal of clinical endocrinology and metabolism, 2010-02, Vol.95 (2), p.601-610

2010

Volltextzugriff (PDF)

MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults

European journal of endocrinology, 2017-03, Vol.176 (3), p.283

2017

Volltextzugriff (PDF)

Overweight/Obese Adults With Pituitary Disorders Require Lower Peak Growth Hormone Cutoff Values on Glucagon Stimulation Testing to Avoid Overdiagnosis of Growth Hormone Deficiency

The journal of clinical endocrinology and metabolism, 2014-12, Vol.99 (12), p.4712-4719

2014

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Aktive Filter

KollektionOxford University Press Journals Current

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(62)

Sprache

Englisch
(62)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(59)
Science & Technology
(59)
Endocrinology & Metabolism
(58)
Humans
(57)
Adult
(49)
Female
(44)
Middle Aged
(42)
Male
(40)
Biological And Medical Sciences
(36)
Medical Sciences
(34)
Endocrinopathies
(23)
Fundamental And Applied Biological Sciences. Psychology
(22)
Vertebrates: Endocrinology
(20)
Aged
(18)
Human Growth Hormone - Deficiency
(16)
Retrospective Studies
(16)
Adolescent
(15)
Feeding. Feeding Behavior
(15)
Human Growth Hormone - Therapeutic Use
(15)
Vertebrates: Anatomy And Physiology, Studies On Body, Several Organs Or Systems
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease

Transsphenoidal Surgery for Cushing Disease After Nondiagnostic Inferior Petrosal Sinus Sampling

Accuracy of Laboratory Tests for the Diagnosis of Cushing Syndrome

Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline

A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update

The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline

LCI699, a Potent 11β-hydroxylase Inhibitor, Normalizes Urinary Cortisol in Patients With Cushing's Disease: Results From a Multicenter, Proof-of-Concept Study

Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome

Exploring Inpatient Hospitalizations and Morbidity in Patients With Adrenal Insufficiency

Potential Cardiac Valve Effects of Dopamine Agonists in Hyperprolactinemia

Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial

Long-Term Safety of Pegvisomant in Patients with Acromegaly: Comprehensive Review of 1288 Subjects in ACROSTUDY

Dopamine Agonists Can Reduce Cystic Prolactinomas

Macimorelin as a Diagnostic Test for Adult GH Deficiency

Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY

Levoketoconazole treatment in endogenous Cushing's syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes

Increasing frequency of combination medical therapy in the treatment of acromegaly with the GH receptor antagonist pegvisomant

Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome

Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency

Use of late-night salivary cortisol to monitor response to medical treatment in Cushing's disease

Radiotherapy, Especially at Young Age, Increases the Risk for De Novo Brain Tumors in Patients Treated for Pituitary/Sellar Lesions

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations

Delayed Remission after Transsphenoidal Surgery in Patients with Cushing’s Disease

MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults

Overweight/Obese Adults With Pituitary Disorders Require Lower Peak Growth Hormone Cutoff Values on Glucagon Stimulation Testing to Avoid Overdiagnosis of Growth Hormone Deficiency

Aktive Filter

Suchergebnisse filtern